Profiel
Cheni Kwok worked as an Associate Director of Business Development at Exelixis, Inc. and as a Director of Business Development at Celera Group.
She was also the Senior Vice President of Business Development at Poniard Pharmaceuticals, Inc. In addition, she worked as a Manager at GlaxoSmithKline Pharmaceuticals Ltd.
Dr. Kwok received an undergraduate degree from Imperial College London and a doctorate degree from the University of Cambridge.
Eerdere bekende functies van Cheni Kwok
| Bedrijven | Functie | Einde |
|---|---|---|
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Corporate Officer/Principal | 02-01-2006 |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 02-01-2004 |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
| PONIARD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Cheni Kwok
| Imperial College London | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| EXELIXIS, INC. | Health Technology |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |